MedTrace Logo

Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning

NCT01052441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2012-12-11

No results posted yet for this study

Summary

The purpose of the study is to evaluate diagnostic performance of high iodine (iopamidol 370 mg/dl) content versus low iodine (iodixanol 300 mg/dl) content for diagnostic accuracy by contrast-enhanced Coronary Cardiac Computed Tomography (CCTA) using a 64-detector-row CT scanner for detection of presence or absence of coronary artery obstruction when compared against invasive coronary angiography, the standard of truth.

Conditions

  • Coronary Arteriosclerosis

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • MDDX LLC

    lead INDUSTRY

Principal Investigators

  • Robert Benton, MD · Capital Cardiology Associates

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-08-31
Completion
2012-09-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01052441 on ClinicalTrials.gov